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A B S T R A C T
We report a rare case of virilizing adrenal cancer with tumorous invasion of the left renal vein in which a retro-
peritoneal adrenalectomy with bail-out nephrectomy was performed. A tumor thrombus infiltrated the wall of the left
adrenal vein and extended into the left renal vein. Initially, a kidney sparing procedure with partial tangential exci-
sion of the involved renal vein wall was performed. After positive vein margins were confirmed with intraoperative his-
tology, the indication for nephrectomy was made. To the authors’ awareness, this is the first report of a virilizing adre-
nal cancer with a tumor thrombus infiltration of the renal vein and surgical tendency for kidney preservation.
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Introduction
Malignant tumors of the adrenal cortex account for
0.05–0.2% of all cancers, with an approximate prevalen-
ce of two new cases per million per year in the general
population1,2. Hormonally active adrenocortical cancers
are present in 30–40% of patients, with Cushing’s syn-
drome being their most frequent clinical presentation3.
Virilization is very rare and occurs in 6–8% of adults
with adrenocortical carcinoma. Preoperative recogni-
tion of a venous tumor extension is of considerable im-
portance in planning the surgical procedure. A poor
prognosis in this neoplasm most frequently affecting
young people makes its early detection pivotal, as the
disease is surgically curable only at early stages.
Case Report
A 35-year-old female, mother of two healthy children,
presented with a history of progressive weakness over
the previous six months and oligoamenorrhea. Exces-
sive hirsutism on the patient’s face, neck and shoulders,
delicate maculopapulous rash on the facial skin and a
moon face were observed. Abdominal and gynecological
examinations did not yield any abnormalities. The pa-
tient was normotensive and normoglycemic. Her renal
biochemical parameters were within normal ranges.
ACTH was 8 ng/L (normal range: 10–100 ng/L), urinary
17-ketosteroids 83.5–119.5 µmol/d (normal range: 17–52
µmol/d), androstendion 96.05 nmol/L (normal range:
2.1–6.4 nmol/L) and serum testosterone 12.1 nmol/L
(normal range: 0.14–2.8 nmol/L). Urinary vanillylman-
delic acid and aldosterone were within normal limits.
Abdominal ultrasonography revealed a solid mass grow-
ing from the upper pole of the left kidney. Computerized
tomography (CT) scan of the abdomen showed a 68x101
mm left adrenal expansion with a tumor thrombus ex-
tension through the adrenal vein into the left renal vein.
The thrombus did not invade the inferior caval vein or
induce retroperitoneal lymphadenopathy (Figure 1).
Opposite adrenal gland was hormonally suppressed and
hypoplastic on CT scan. Lumbotomy through 10th inter-
costal space and extra peritoneal extirpation of adrenal
gland with tumor and tumor thrombus were under-
taken. The renal hylus was clamped, the renal vein in-
cised and its wall partially excised. The tumor thrombus
was completely removed en block with tumor (Figure 2).
The renal vein was sutured in warm ischemia lasting 7
minutes. Kidney reperfusion was excellent. As intra-
operative histology examination revealed that the tu-
mor infiltrated the resected renal vein margins, neph-
rectomy was performed. Pathologically, the cancer was
found to be adrenal cortical with the endocrine tumor
cell differentiation. Similar tumor cells were also found
in renal vein margins. Kidney and lymph nodes were tu-
mor free. Serum testosterone level fell to its normal
value within 20 days after the surgery. Glucocorticoids
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were gradually withdrawn over the first postoperative
month. The first postoperative abdominal CT was done
three months after the surgery and was normal. Seven
months after the surgery, the patient’s serum testoster-
one values rose again. A control CT scan revealed multi-
ple hepatic metastases and retro peritoneal lympha-
denopathy. Mitotane therapy was started. The patient
died 13 months after the surgery.
Discussion
Virilizing adrenal cancer is extremely rare tumor
with a high malignant potential. In the present case,
the authors’ view was that a thrombotic tumor exten-
sion into the renal vein was not necessarily associated
with nephrectomy. However, intraoperative histological
examination after a successful kidney revascularization
presented an indication for nephrectomy. Reviewing the
literature reports on 12 women with virilizing adrenal
cancer, none of them was found with a renal vein tumor
thrombus. A positive dexamethasone test is useful in de-
tection of virilizing adrenal cancer3 during the preopera-
tive evaluation of hirsute women with serum cortisol,
testosterone and androstendion elevations. Among cur-
rent radiological diagnostic methods, MRI distinguishes
among adrenocortical tumors the most accurately; it
compares the ratio of individual signal intensities of
each type of the adrenal mass to that of the liver4, and
provides information about vascular invasion of the tu-
mor. In the present case, CT scanning was used in diag-
nostic blood vessel evaluation. In our patient, a radical
surgery could not prevent vascular spread of the disease
into the liver. Mitotane has been used in altering ex-
tratumoral cortisol and androgens metabolism. In this
patient, it proved ineffective in prolonging survival. Var-
ious studies combining mitotane and cytotoxic chemo-
therapy did not show significant prolongation of sur-
vival5–7. Therefore, in patients with adrenal neoplasms,
surgical removal of the tumor at early stages gives these
patients the only chance for survival.
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Fig. 2. Adrenal tumor with the tumor thrombus extension
and infiltration of adrenal vein (on surgical sutures).
Fig. 1. Computer tomography (CT) scan. Large left adrenal tu-
mor (1) with the arrow pointing on the tumor thrombus and the
kidney (2).
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VIRILIZIRAJU]I KARCINOM NADBUBRE@NE @LIJEZDE I NEIZBJE@NA NEFREKTOMIJA
S A @ E T A K
U ovom radu je prikazan vrlo rijedak slu~aj viriliziraju}eg karcinoma nadbubre`ne `lijezde s invazijom tumora u
lijevu renalnu venu, kod kojega je u~injena adrenalektomija s neizbje`nom nefrektomijom. Tumorski tromb je infil-
trirao stjenku lijeve nadbubre`ne vene i pro{irio se u lijevu bubre`nu venu. Isprva je u~injena po{tedna operacija s
prezervacijom lijevog bubrega na kojem je u~injena tangencijalna ekscizija zahva}enog dijela stjenke bubre`ne vene.
Indikacija za nefrektomiju je postavljena nakon u~injene intraoperativne patohistolo{ke analize, kada je potvr|en
pozitivni venski rub. Prema saznanjima autora, ovo je prvo izvje{}e o viriliziraju}em tumoru nadbubre`ne `lijezde s
tumorskom infiltracijom bubre`ne vene, kod kojeg se nastojao sa~uvati bubreg.
